JULIA MARIE EASTLAND

Insider Reports History

Location
San Diego, CA
Signature
/s/ James B. Bucher, attorney-in-fact for Julia Marie Eastland
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JULIA MARIE EASTLAND:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lantheus Holdings, Inc. Director Common Stock 3,882 $402,330 $103.64 14 May 2025 Direct
Zentalis Pharmaceuticals, Inc. CEO & President, Director Common Stock 79,133 $189,357 $2.39 09 Feb 2026 Direct
DYNAVAX TECHNOLOGIES CORP Director Common Stock 16,071 $183,049 $11.39 23 May 2024 Direct
CalciMedica, Inc. Director Common Stock 1,429 $5,290 $3.70 23 Mar 2023 Direct
Zentalis Pharmaceuticals, Inc. CEO & President, Director Stock Option (Right to Buy) 775,000 08 Jan 2026 Direct
DYNAVAX TECHNOLOGIES CORP Director Stock Option (Right to Buy) 22,500 23 May 2024 Direct
Lantheus Holdings, Inc. Director Stock Option (right to buy) 4,543 14 May 2025 Direct
CalciMedica, Inc. Director Restricted Stock Unit 0 23 Mar 2023 Direct
Harpoon Therapeutics, Inc. President and CEO, Director Common Stock 0 11 Mar 2024 Direct
Harpoon Therapeutics, Inc. President and CEO, Director Employee Stock Option (Right to Buy) 0 11 Mar 2024 Direct

Insider Reports Filed by JULIA MARIE EASTLAND

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZNTL Zentalis Pharmaceuticals, Inc. 06 Feb 2026 2 -$21,239 4 CEO & President, Director 10 Feb 2026, 21:09
ZNTL Zentalis Pharmaceuticals, Inc. 08 Jan 2026 1 $0 4 CEO & President, Director 09 Jan 2026, 20:33
LNTH Lantheus Holdings, Inc. 14 May 2025 2 $0 4 Director 16 May 2025, 16:39
ZNTL Zentalis Pharmaceuticals, Inc. 03 Feb 2025 2 $0 4 CEO & President, Director 05 Feb 2025, 18:29
ZNTL Zentalis Pharmaceuticals, Inc. 31 Jan 2025 1 +$49,345 4 CEO & President, Director 04 Feb 2025, 16:37
ZNTL Zentalis Pharmaceuticals, Inc. 02 Dec 2024 1 $0 4 CEO & President, Director 03 Dec 2024, 19:02
ZNTL Zentalis Pharmaceuticals, Inc. 13 Nov 2024 0 $0 3 CEO & President, Director 13 Nov 2024, 17:45
LNTH Lantheus Holdings, Inc. 10 Sep 2024 2 $0 4 Director 12 Sep 2024, 17:57
LNTH Lantheus Holdings, Inc. 03 Sep 2024 0 $0 3 Director 09 Sep 2024, 16:59
DVAX DYNAVAX TECHNOLOGIES CORP 23 May 2024 2 $0 4 Director 28 May 2024, 20:30
/report/000095017024029430-eastland-julia-marie-2024-03-11 Harpoon Therapeutics, Inc. 11 Mar 2024 4 $0 4 President and CEO, Director 11 Mar 2024, 17:17
/report/000095017024003365-eastland-julia-marie-2024-01-07 Harpoon Therapeutics, Inc. 07 Jan 2024 1 $0 4 President and CEO, Director 09 Jan 2024, 16:30
/report/000120919123056805-eastland-julia-marie-2023-11-26 Harpoon Therapeutics, Inc. 26 Nov 2023 1 $0 4 President and CEO, Director 28 Nov 2023, 16:30
DVAX DYNAVAX TECHNOLOGIES CORP 26 May 2023 2 $0 4 Director 31 May 2023, 17:23
CALC CalciMedica, Inc. 23 Mar 2023 2 $0 4 Director 27 Mar 2023, 19:57
/report/000120919123005030-eastland-julia-marie-2023-01-24 Harpoon Therapeutics, Inc. 24 Jan 2023 1 $0 4 President and CEO, Director 26 Jan 2023, 15:05
CALC GRAYBUG VISION, INC. 02 Jun 2022 2 $0 4 Director 03 Jun 2022, 17:35
DVAX DYNAVAX TECHNOLOGIES CORP 26 May 2022 2 $0 4 Director 27 May 2022, 17:01
/report/000120919121063586-eastland-julia-marie-2021-11-08 Harpoon Therapeutics, Inc. 08 Nov 2021 1 $0 4 President and CEO, Director 09 Nov 2021, 15:02
CALC GRAYBUG VISION, INC. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 18:36
DVAX DYNAVAX TECHNOLOGIES CORP 28 May 2021 1 $0 4 Director 02 Jun 2021, 19:04
/report/000120919121032956-eastland-julia-marie-2021-05-04-restatement Harpoon Therapeutics, Inc. 04 May 2021 1 $0 4/A Director 14 May 2021, 20:02